Interaction of cimetidine with P450 in a mouse model of hepatocarcinogenesis initiation

por Caballero, F., Gerez, E., Batlle, A., Vazquez, E.

Preventive aspirin treatment of streptozotocin induced diabetes: Blockage of oxidative status and revertion of heme enzymes inhibition

por Caballero, F., Gerez, E., Batlle, A., Vazquez, E.

Altered heme pathway regulation and drug metabolizing enzyme system in a mouse model of hepatocarcinogenesis: Effect of veronal

por Gerez, E., Vazquez, E., Caballero, F., Polo, C., Batlle, A.

Drug metabolizing enzyme system and heme pathway in hepatocarcinogenesis

por Vazquez, E., Gerez, E., Caballero, F., Polo, C., Batlle, A.

Beta-carotene partially prevents the damage induced by 1,4- dimethylaminoazobenzene in mice

por Gerez, E., Vazquez, E., Caballero, F., Del C Batlle, A.M.

On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice

por Caballero, F., Gerez, E., Oliveri, L., Falcoff, N., Batlle, A., Vazquez, E.

Hepatic enzymatic metabolism alterations and oxidative stress during the onset of carcinogenesis: Protective role of α-tocopherol

por Gerez, E., Caballero, F., Vazquez, E., Polo, C., Del C. Batlle, A.M.

Heme oxygenase, aminolevulinate acid synthetase and the antioxidant system in the brain of mice treated with porphyrinogenic drugs

por Rodriguez, J.A., Martinez, M.D.C., Gerez, E., Batlle, A., Buzaleh, A.M.

Heme biosynthesis pathway regulation in a model of hepatocarcinogenesis pre-initiation

por Polo, C.F., Vazquez, E.S., Caballero, F., Gerez, E., Batlle, A.M.d.C.

HFE gene mutations in patients with altered iron metabolism in Argentina

por Rossetti, M.V., Méndez, M., Afonso, S., Gerez, E., Batlle, A., Muñoz, A., Parera, V.E.

STZ-induced diabetes in mice and heme pathway enzymes. Effect of allylisopropylacetamide and α-tocopherol

por Polo, C.F., Vázquez, E.S., Gerez, E.N., Caballero, F.A., del C. Batlle, A.M.

Reducing sugars trigger δ-aminolevulinic dehydratase inactivation evidence of in vitro aspirin prevention

por Caballero, F.A., Gerez, E.N., Polo, C.F., Vazquez, E.S., Del C. Batlle, A.M.

Acute intermittent porphyria in argentina: An update

por Cerbino, G.N., Gerez, E.N., Varela, L.S., Melito, V.A., Parera, V.E., Batlle, A., Rossetti, M.V.

Pleiotropic effects of 5-aminolevulinic acid in mouse brain

por Lavandera, J., Rodríguez, J., Ruspini, S., Meiss, R., Zuccoli, J.R., Martínez, M.D.C., Gerez, E., Batlle, A., Buzaleh, A.M.

Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs

por Ruspini, S.F., Zuccoli, J.R., Lavandera, J.V., Martínez, M.D.C., Oliveri, L.M., Gerez, E.N., Batlle, A.M.D.C., Buzaleh, A.M.

Heme metabolism: The janus nature of precursorsand porphyrins

por Rossetti, M.V., Buzaleh, A.M., Parera, V.E., Fukuda, H., Lombardo, M.E., Lavandera, J., Gerez, E.N., Melito, V.A., Zuccoli, J.R., Ruspini, S.F., Puente, V.R., Diez, B.A., Teijo, M.J., Cerbino, G.N., Varela, L.S., Guolo, M.N., Del Carmen Batlle, A.M.